Tag Archives: tag2

Venture capital indicates trends of digital health

The pharmaceutical industry has been experiencing some fundamental changes–outstanding efficacy and cost-effectiveness is more essential than ever for a drug to gain market access; the traditional one-size-fits-all blockbuster strategy has been increasingly challenged by personalized medicine, and the use of medicine is declining. These changes suggest the pharmaceutical industry needs to transform from “drug maker” to […]

2 Comments Continue Reading →